← Back to Search

Deliberate practice for Traumatic Injury

N/A
Waitlist Available
Led By Deepika Mohan, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Board certified physicians who work at non-trauma centers in the United States
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks post-intervention (deliberate practice) or 3 weeks post-enrollment (control)
Awards & highlights

Study Summary

This trial will test whether using deliberate practice with a coach can increase engagement.

Eligible Conditions
  • Traumatic Injury

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks post-intervention (deliberate practice) or 3 weeks post-enrollment (control)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks post-intervention (deliberate practice) or 3 weeks post-enrollment (control) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants Who Signed up for the Intervention That Completed All 3 Coaching Sessions.
Secondary outcome measures
Number of Participants Who Describe Coaching as Acceptable.
Under-triage

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Deliberate practiceExperimental Treatment1 Intervention
Trainees will be paired with a coach, and will meet, once per week for thirty minutes, over a three week period. During the training session, coach-trainee dyads will play a puzzle video game, and will discuss contextual cues that should inform triage decisions. At the completion of the three weeks, trainees will complete a semi-structured, debriefing interview and a virtual simulation to assess triage performance.
Group II: ControlActive Control1 Intervention
Participants in the control group will complete a virtual simulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deliberate practice
2021
N/A
~80

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,004,098 Total Patients Enrolled
University of PittsburghLead Sponsor
1,712 Previous Clinical Trials
16,346,339 Total Patients Enrolled
Deepika Mohan, MDPrincipal InvestigatorUniversity of Pittsburgh
5 Previous Clinical Trials
2,128 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~22 spots leftby Mar 2025